3D Camera - Telemedical Foot Ulcer Treatment

A Feasibility Study on the Development of 3D Optic Ulcer Camera

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01870934

Enrollment

Registered

2013-06-06

Start date

2013-01-31

Completion date

2013-11-30

Last updated

2013-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Foot Ulcers

Keywords

Telemedicine, Diabetes, Foot Ulcers

Brief summary

Diabetic foot ulcers are deep wounds that occur as a result of nerve damage in the feet (peripheral neuropathy). Amputation is a common consequence of diabetic foot ulcers; approximately 85% of all diabetes-related amputations are caused by foot ulcers. The ulcer treatment is extensive, resource demanding and highly specialized and necessitates involvement of patient, hospital and local in-home care personnel. The 3D photo optic camera project aims at a much more efficient and precise method for diagnosis and treatment of foot ulcers. The Department of Endocrinology and the section for LEAN and Innovation at Odense University Hospital has developed a prototype for a 3D camera that takes pictures and measurements of the ulcer that can provide the basis for correct diagnosis and treatment of the ulcer. The camera was developed in close cooperation with TECCLUSTER A/S, Svendborg Municipality, Team Online and ComMed.

Interventions

DEVICECamera

No real intervention, but a comparison of different methods including the new medical device 3D camera.

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with diabetic foot ulcers, which has been the diagnosis, stratification (eg ischemia, neuropathy, etc.) and treatment according to current guidelines refer Diabetic Foot Study Group. Age 18-90 years

Exclusion criteria

* Superficial wounds (superficial skin defect with loss of substance in 5 x 5 mm)

Design outcomes

Primary

Measure	Time frame
Comparison of 3D image and normal assessment of wounds	outcome measure is assessed in 2013

Secondary

Measure	Time frame
Comparison of 3D and 2D image assessment of wounds	november 2013

Countries

Denmark

Contacts

Primary ContactBenjamin Sc Rasmussen, M.D.

bsr@rsyd.dk

Backup ContactBenjamin Schnack Sc Rasmussen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026